NCT04887922

Brief Summary

The goal of this study is to determine the efficacy of incentive spirometry (IS) to improve pulmonary function in the preoperative and postoperative surgical setting. The investigators hypothesize that IS will improve pulmonary function for patients undergoing major abdominal surgery when controlling for protocol compliance. Additionally, the investigators hypothesize that a digital IS device enabled with a text message-based mobile health intervention will improve pulmonary pre-habilitation and rehabilitation, as well as postoperative compliance with the IS device.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
2

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started May 2022

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 10, 2021

Completed
4 days until next milestone

First Posted

Study publicly available on registry

May 14, 2021

Completed
12 months until next milestone

Study Start

First participant enrolled

May 3, 2022

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 27, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 27, 2022

Completed
5 months until next milestone

Results Posted

Study results publicly available

May 17, 2023

Completed
Last Updated

May 17, 2023

Status Verified

April 1, 2023

Enrollment Period

8 months

First QC Date

May 10, 2021

Results QC Date

March 30, 2023

Last Update Submit

April 23, 2023

Conditions

Outcome Measures

Primary Outcomes (1)

  • Change in Forced Expiratory Volume in One Second Parameter (FEV1)

    From baseline to day-of-surgery preoperative

Secondary Outcomes (5)

  • Change in Forced Vital Capacity (FVC)

    From baseline to day-of-surgery preoperative

  • Change in Pulse Oximetry

    From baseline to day-of-surgery preoperative

  • Change in Forced Expiratory Volume in One Second Parameter (FEV1)

    From day 1 to postoperative day 3

  • Change in Forced Vital Capacity (FVC)

    From day 1 to postoperative day 3

  • Change in Pulse Oximetry

    From day 1 to postoperative day 3

Study Arms (5)

Pre-Surgery: No Incentive Spirometry (IS)

NO INTERVENTION

-Will not receive a incentive spirometer prior to surgery

Pre-Surgery: Standard Incentive Spirometry (IS)

EXPERIMENTAL

* Will receive a conventional spirometer prior to surgery * Will be asked to perform spirometry 30 times per day.

Device: Conventional spirometer

Pre-Surgery: Digital Incentive Spirometry (IS) + Text Message

EXPERIMENTAL

* Will receive the digital incentive spirometer (Spirobank G) that is compatible with health monitoring software developed by ZEPHYRx®. The digital spirometer couples with a HIPAA-compliant mobile application that calculates and stores pulmonary function test (PFT) results. * Will be asked to perform spirometry 10 times per hour, every hour while awake, every day for at least 7 days prior to surgery. Absence of spirometry for 24 hours will trigger a text message reminder to encourage compliance with IS.

Device: MIR Spirobank GDevice: ZEPHYRx®

Post-Surgery: Standard Incentive Spirometry (IS)

ACTIVE COMPARATOR

* After surgery, the participants will receive a conventional spirometer. * Will be instructed to perform spirometry 10 times per hour, every hour while awake through postoperative Day 3 * The conventional spirometer will be equipped with an accelerometer that will allow the research team to determine whether the spirometer moves throughout the patients' postoperative stay (as a proxy for IS use)

Device: Conventional spirometer

Post-Surgery: Digital Incentive Spirometry (IS) + Text Message

EXPERIMENTAL

* After surgery, the participants will receive the digital incentive spirometer (Spirobank G) that is compatible with health monitoring software developed by ZEPHYRx®. The digital spirometer couples with a HIPAA-compliant mobile application that calculates and stores pulmonary function test (PFT) results. * Will be instructed to perform spirometry 10 times per hour, every hour while awake through postoperative Day 3 * Will receive text reminders to perform spirometry if they do not perform spirometry in a 24-hour period.

Device: MIR Spirobank GDevice: ZEPHYRx®

Interventions

FDA-approved, Bluetooth digital spirometer

Post-Surgery: Digital Incentive Spirometry (IS) + Text MessagePre-Surgery: Digital Incentive Spirometry (IS) + Text Message
ZEPHYRx®DEVICE

ZEPHYRx® has developed a 1) digital Bluetooth-enabled IS that allows for the continuous and objective remote monitoring of patient compliance with pre- and postoperative IS via a smartphone app and online provider dashboard.

Post-Surgery: Digital Incentive Spirometry (IS) + Text MessagePre-Surgery: Digital Incentive Spirometry (IS) + Text Message

Will be provided to participants

Post-Surgery: Standard Incentive Spirometry (IS)Pre-Surgery: Standard Incentive Spirometry (IS)

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients scheduled to undergo major abdominal surgery with expected postoperative length of stay of 48 hours or more.
  • Access to a smartphone.
  • At least 18 years of age.
  • Ability to understand and willingness to sign an IRB approved written informed consent document.

You may not qualify if:

  • Younger than 18 years of age
  • No access to a smartphone

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Washington University School of Medicine

St Louis, Missouri, 63110, United States

Location

Related Links

Results Point of Contact

Title
Chet Hammill, M.D., MCR
Organization
Washington University School of Medicine

Study Officials

  • Chet Hammill, M.D., MCR

    Washington University School of Medicine

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
Yes

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
CROSSOVER
Model Details: * Prior to surgery, participants will be randomized into three groups: (1) control group with no IS, (2) standard IS, and (3) digital IS + text message. * Following surgery, patients will be re-randomized into two groups: (1) standard IS, and (2) digital IS + text message.
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 10, 2021

First Posted

May 14, 2021

Study Start

May 3, 2022

Primary Completion

December 27, 2022

Study Completion

December 27, 2022

Last Updated

May 17, 2023

Results First Posted

May 17, 2023

Record last verified: 2023-04

Data Sharing

IPD Sharing
Will not share

Locations